Skip to main content

Month: August 2025

Pan American Announces Private Placement for up to C$3M

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Aug. 07, 2025 (GLOBE NEWSWIRE) — Pan American Energy Corp. (the “Company” or “Pan American”) (CSE: PNRG) (OTCQB: PAANF) (FRA: SS6) is pleased to announce that it intends to complete a non-brokered private placement of up to 4,000,000 units (“Units”), at a price of C$0.50 per Unit, and of up to 1,538,462 flow-through units (“Flow-Through Units”), at a price of C$0.65 per Flow-Through Unit, for gross aggregate proceeds of up to C$3,000,000. Each Unit will consist of one (1) common share of the Company (each, a “Share”) and one (1) Share purchase warrant of the Company (each, a “Warrant”), with each Warrant entitling the holder to acquire one (1) Share (each, a “Warrant Share”) at a price of C$0.65 for a period of twenty-four...

Continue reading

Refined Energy Corp. and Eagle Plains Resources Ltd. sign an amendment to the Option Agreement for the Dufferin Project in the Athabasca Basin

VANCOUVER, British Columbia, Aug. 07, 2025 (GLOBE NEWSWIRE) — Refined Energy Corp. (CSE: RUU | OTC: RRUUF | FRA: CWA0) (“Refined” or the “Company“) announces that it has signed a further amendment with Eagle Plains Resources Ltd. (“EPL“) on July 29, 2025 (the “Amended Agreement”), to the option agreement dated February 26, 2024, which was amended on January 30, 2025 (the “Agreement”), under which the Company has the right to acquire up to an undivided seventy-five percent (75%) interest in and to the Dufferin North and Dufferin West Property (the “Property”). The Company and EPL agree to extend the due dates of the following:(i)   the additional cash payment of $100,000 from December 31, 2025, to April 30, 2026;(ii)   the exploration expenditures on the Property of an additional $350,000 from...

Continue reading

TC Transcontinental Acquires Canva Group Businesses to Accelerate Growth of its In-Store Marketing Segment

MONTRÉAL, Aug. 07, 2025 (GLOBE NEWSWIRE) — Transcontinental Inc. (TSX: TCL.A TCL.B) announces the acquisition of two Canva Group businesses, Mirazed Inc., located in Saint-Hubert, Quebec, and Intergraphics Decal Limited, located in Winnipeg, Manitoba. This strategic transaction follows the acquisition of Middleton Group in June and strengthens TC Transcontinental’s position as a leader in in-store marketing. Mirazed is recognized for its cutting-edge expertise in screen printing as well as large format digital printing, the production of promotional displays and point-of-purchase (POP) signage. Intergraphics specializes in industrial screen and digital printing. Together, these entities employ more than 200 skilled people and operate state-of-the-art production facilities that will significantly enhance TC Transcontinental’s...

Continue reading

Sutro Biopharma Reports Second Quarter 2025 Financial Results and Business Highlights

– On track to initiate FIH study with STRO-004, potential best-in-class Tissue Factor ADC, in the second half of 2025 – – Expanded breadth of preclinical data across pipeline, including STRO-006 and dual-payload ADCs – – Entered research collaboration with the FDA to advance regulatory standards for ADCs – – Industry veteran Greg Chow appointed as Chief Financial Officer – – Cash, cash equivalents and marketable securities as of June 30, 2025 of $205.1 million, with cash runway into early 2027 – SOUTH SAN FRANCISCO, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) — Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), an oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today reported its financial results for the second quarter of 2025 and recent business highlights. “In the second quarter,...

Continue reading

Legacy Housing Corporation Reports Second Quarter 2025 Financial Results

BEDFORD, Texas, Aug. 07, 2025 (GLOBE NEWSWIRE) — Legacy Housing Corporation (“Legacy” or the “Company,” NASDAQ: LEGH) today announced its financial results for the second quarter ended June 30, 2025. Financial HighlightsNet revenue for the second quarter of 2025 was $50.2 million, an increase of 18.0% from the second quarter of 2024. Income from operations for the second quarter of 2025 was $16.8 million, an increase of 4.9% from the second quarter of 2024. Net income for the second quarter of 2025 was $14.7 million, a decrease of 9.2% from the second quarter of 2024. Basic earnings per share for the second quarter of 2025 was $0.61, a decrease of 9.0% from the second quarter of 2024. Book value per share1 for the second quarter of 2025 was $21.32, an increase of 11.2% from the second quarter of 2024. The Company repurchased...

Continue reading

Elicio Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Updates

Recent positive recommendation by the Independent Data Monitoring Committee (“IDMC”) to continue ELI-002 7P randomized Phase 2 study in pancreatic cancer without modifications to final analysis Event-driven final analysis focused on disease-free survival (“DFS”) expected in Q4 2025 Secured $10 million financing in Q2 2025; Current cash position expected to support operations beyond anticipated AMPLIFY-7P Phase 2 final analysis BOSTON, Aug. 07, 2025 (GLOBE NEWSWIRE) — Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio” or the “Company”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer, today reported financial results for the second quarter ended June 30, 2025, and provided recent corporate and clinical updates. “Most recently, we were pleased to receive the IDMC’s...

Continue reading

Alaris Equity Partners Income Trust Releases 2025 Second Quarter Financial Results

NOT FOR DISTRIBUTION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAW. CALGARY, Alberta, Aug. 07, 2025 (GLOBE NEWSWIRE) — Alaris Equity Partners Income Trust (together, as applicable, with its subsidiaries, “Alaris” or the “Trust“) is pleased to announce its results for the three and six months ended June 30, 2025. All amounts below are in Canadian dollars unless otherwise noted. Highlights:Alaris’s Net book value (1) per unit of $23.57 at June 30, 2025 decreased by $0.77 from March 31, 2025. . The $0.59 in growth of per unit earnings from Q1 2025 was offset by $0.98 per unit unrealized foreign exchange loss related to the rise in the Canadian/US dollar exchange rate as well as the Trust’s quarterly distribution of $0.34 per unit; Total revenue...

Continue reading

ATN Reports Second Quarter 2025 Results; Reaffirms 2025 Outlook

Second Quarter 2025 vs. Second Quarter 2024 Financial HighlightsExpanded high-speed broadband homes passed by 8% Grew total high-speed subscribers by 1% Second-quarter revenues declined 1% to $181.3 million Second quarter operating income decreased to $0.2 million Second quarter net loss was $(7.0) million, or $(0.56) per share Second quarter Adjusted EBITDA1 decreased 6% to $45.8 million Net cash provided by operating activities for the year-to-date period increased 2% to $59.8 million Capital expenditures for the year-to-date period were $42.0 million (net of $45.9 million reimbursements) Net Debt Ratio3 was 2.58x on June 30, 2025Reaffirmed Outlook for Full Year 2025Revenue, excluding construction revenue, is expected to be in line with last year’s result of $725 million Adjusted EBITDA2 is expected to be essentially flat with...

Continue reading

Serve Robotics Announces Second Quarter 2025 Results

Delivery Volume growth of nearly 80% quarter over quarterLaunched Atlanta market and announced Chicago launch in the coming weeksSecond quarter revenue of $642 thousand, a 46% increase versus Q1 2025Maintained a strong liquidity position of $183 millionSAN FRANCISCO, Aug. 07, 2025 (GLOBE NEWSWIRE) — Serve Robotics Inc. (the “Company” or “Serve”) (Nasdaq: SERV), a leading autonomous sidewalk delivery company, today announced financial results for the second quarter ended June 30, 2025. “Serve is building the world ahead, where autonomous last mile transportation is ubiquitous and foundational,” said Dr. Ali Kashani, Serve’s Co-founder and CEO. “This quarter marked a major step forward as we expanded into new markets, scaled operations, and fueled our autonomy flywheel to an unprecedented degree. With every successful delivery,...

Continue reading

Coherus Oncology Reports Second Quarter 2025 Financial Results and Provides Business Update

– LOQTORZI net revenue was $10.0 million, a 36% increase over Q1 2025 – – Data readouts for CHS-114 and casdozokitug on track for 1H 2026 – – Q2 2025 ending cash, cash equivalents and marketable securities of $238 million – – Conference call today at 5:00 p.m. Eastern Time – REDWOOD CITY, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) — Coherus Oncology, Inc. (Nasdaq: CHRS), today reported financial results for the second quarter ended June 30, 2025 and provided an overview of recent business highlights. “Coherus Oncology is dedicated to significantly extending survival for people with cancer,” said Denny Lanfear, Coherus Chairman and Chief Executive Officer. “We are executing well commercially, and our focus on maximizing LOQTORZI’s potential in nasopharyngeal carcinoma has resulted in a 36% net revenue increase over Q1 2025 to $10.0...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.